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TO THE EDITOR
An endemic form of pemphigus folia-
ceus (PF) exists and is virtually exclu-
sive to certain inland states of Brazil,
where it is known as fogo selvagem (FS;
Diaz et al., 1989b). FS shows similar
clinical, histological, and immuno-
logical features to those observed in
nonendemic PF (Stanley et al., 1986;
Diaz et al., 1989a). The etiology of FS
is unknown, but blister formation is
mediated predominantly by IgG4 (Rock
et al., 1989). Moreover, a progression
from preclinical to clinical disease is
associated with a sharp rise in IgG4
anti-desmoglein 1 (Dsg1; Warren et al.,
2003), and these autoantibodies are
predictors of FS (Qaqish et al., 2009).
Emergence of self-reactive IgG4 anti-
Dsg1 in FS is a mystery; however, there
are some promising circumstantial
clues that point toward the etiology of
the disease. For example, the antigen-
selected nature of anti-Dsg1 (Qian
et al., 2009) and the presence of IgM
anti-Dsg1 in healthy individuals in
endemic areas of FS (Diaz et al.,
2008) strongly suggest a recent or an
ongoing exposure of settlers in these
endemic regions to an environmental
antigen(s) (Aoki et al., 2004; Diaz et al.,
2004, 2008).
IgG4 and IgE antibodies develop
in individuals chronically exposed to
environmental allergens or during
immunotherapy of patients with aller-
gic diseases (Lichtenstein et al., 1968;
Muller, 2005). Little is known about
the IgE anti-Dsg1 response in FS, but
recently Nagel et al. (2009) have
reported that IgE anti-desmoglein 3
(Dsg3) correlated with disease activity
in pemphigus vulgaris (PV) patients. In
this investigation, we have evaluated
the IgE, IgM, and IgG4 anti-Dsg1
responses in a large cohort of FS
patients and control individuals. A total
of 558 sera were tested for IgE anti-
Dsg1. Patient cohorts included 143 FS
patients (Brazil), 39 nonendemic PF
patients (United States and Japan), and
59 PV patients (United States and
Japan). Healthy control (HC) cohorts
included 161 healthy individuals living
in the endemic areas of FS (Brazil), 57
healthy individuals from nonendemic
areas (Brazil), and 99 healthy indivi-
duals from United States (n¼76)
and Japan (n¼23). Dsg1-specific ELISA
were carried out as described (Qian
et al., 2007) with a minor modification,
i.e., the use of biotin-labeled mouse
anti-human IgE and horseradish perox-
idase-conjugated streptavidin (South-
ernBiotech, Birmingham, AL). The
levels of IgE anti-Dsg1 were expressed
as index value units as reported by
Amagai et al. (1999) and Diaz et al.
(2008; Qaqish et al., 2009).
The distribution of IgE index values
in sera from FS, PF, and healthy
individuals from Brazilian, Japanese,
and US donors is shown as box plots
(Figure 1a). The statistical comparisons
of these groups are shown in Table 1.
The IgE anti-Dsg1 index values in the FS
group were higher than in the other
sets, whereas HCs from US and Japan
showed the lowest values. The differ-
ences in means between the FS group
and all other groups tested were statis-
tically significant at the 0.05 level.
The difference between HCs from end-
emic regions of Brazil and nonendemic
regions of Brazil was not significant.
However, the difference between
HCs from Brazil and United States/
Japan was statistically significant.
The significantly different IgE anti-
Dsg1 levels between the FS and the PF
groups in United States/Japan indicate
that the IgE anti-Dsg1 response in FS is
a distinctive serological feature of this
disease. The significant difference in
IgE anti-Dsg1 between HCs in Brazil
(endemic and nonendemic) and HCs
in United States/Japan needs to be
explored in the future. The lack of
difference between HC endemic Brazil
and HC nonendemic is likely explained
by the fact that these groups share
certain living conditions, and per-
haps environmental antigens. However,
these antigens may not be present in the
United States and Japan.
We then analyzed the correlation
between the IgE and IgG4 anti-Dsg1
responses in 143 FS and 317 HC
individuals. Figure 1b shows a plot of
IgE against IgG4 anti-Dsg1, with super-
imposed regression lines, in the FS
(red) and HC groups (blue). We found
a correlation between IgE and IgG4 in
the FS group (Spearman’s correlation
r¼ 0.32, Po0.001), and less correla-
tion in the HC group (r¼0.15,
P¼0.07), suggesting that the genera-
tion of these autoantibodies in FS may
be linked and arising because of sensi-
tizing to a common environmental
allergen. These patterns of IgG4 and
IgE responses are similar to those
observed in allergic patients. Ongoing
studies may demonstrate a stronger
correlation between IgE and IgG4 anti-
Dsg1 systems when testing sera from
patients at different clinical and immu-
nological stages of evolution.
To evaluate the humoral IgM, IgG4,
and IgE anti-Dsg1 responses in FS and
HC groups, we extracted data on IgM
and IgG4 anti-Dsg1 for the same sub-
jects utilized in previous publications
(Diaz et al., 2008; Qaqish et al., 2009).
A receiver operating characteristic
(ROC) curve for IgM, IgE, and IgG4
anti-Dsg1 index values was used to
determine a cutoff point for sensitivity
and specificity as described (Diaz et al.,
2008; Qaqish et al., 2009). The per-
centages of positive sera for IgM, IgE,
and IgG4 anti-Dsg1 in the different
groups were plotted and shown in
Figure 1c. It is apparent that the triple
Abbreviations: Dsg1, desmoglein 1; Dsg3, desmoglein 3; FS, fogo selvagem; HC, healthy control
PF, pemphigus foliaceus; PV, pemphigus vulgaris; ROC, receiver operating characteristic
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response of IgM, IgG4, and IgE anti-
Dsg1 is much higher in FS patients than
in HC from the same endemic regions
and HC from nonendemic regions
of Brazil and United States/Japan (w2,
Po0.05, for IgM, IgE, and IgG4 anti-
Dsg1). The percentages of positive
individuals for IgM and IgE anti-Dsg1
were higher in the FS group (58 and
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Figure 1. IgE and IgG4 anti-desmoglein 1 (Dsg1) in fogo selvagem (FS) patients and control groups. (a) Box plots of IgE anti-Dsg1 in FS and pemphigus
foliaceus (PF) patients and healthy controls (HCs). The horizontal lines within the box plots indicate the median values; the lower and upper ends of the boxes
represent the 25th and 75th percentiles. (b) The correlation between anti-Dsg1 IgE and IgG4 in FS patients and healthy controls. Blue triangles and blue line
indicate healthy controls; red circles and red line indicate FS patients. (c) IgM, IgE, and IgG4 anti-Dsg1 in FS, PF, pemphigus vulgaris (PV), bullous pemphigoid,
and HCs. Percentages of positive anti-Dsg1 sera for each group are shown in green bars (IgM), yellow bars (IgE), and blue bars (IgG4).
Table 1. Comparison of the IgE anti-Dsg1 autoantibodies in FS and control groups
Comparison
Difference between means
of index value
Simultaneous 95%
confidence limit P-value
FS versus PF United States/Japan 0.69 0.42 0.96 0.05
FS versus HC endemic area Brazil 0.90 0.73 1.07 0.05
FS versus HC nonendemic area Brazil 1.01 0.78 1.25 0.05
FS versus HC United States/Japan 1.32 1.13 1.51 0.05
PF United States/Japan versus HC United States/Japan 0.63 0.35 0.91 0.05
HC endemic area Brazil versus HC nonendemic area Brazil 0.12 0.11 0.34 NS
HC United States/Japan versus HC endemic area Brazil 0.42 0.61 0.23 0.05
HC United States/Japan versus HC nonendemic area Brazil 0.31 0.55 0.06 0.05
Abbreviations: Dsg1, desmoglein 1; FS, fogo selvagem; HC, healthy control; NS, nonsignificant comparison; PF, pemphigus foliaceus.
Analysis of differences between groups used one-way analysis of variance with adjustment for multiple comparisons by Tukey’s studentized range test.
Analysis was done on log(IgE+40) and log(IgG4+2) as these transformed variables were approximately normally distributed. Analysis was done in the R 2.9
software (R Foundation for Statistical Computing, Vienna, Austria).
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81%, respectively) than in all other
groups (w2, Po0.05). As expected and
also shown in Figure 1c, IgG4 anti-
Dsg1 was detected in a large number
of FS, PF, and PV patients (90, 77, and
33% respectively), which is a known
feature of these diseases. These findings
suggest a persistent antigenic stimula-
tion of the immune system of indivi-
duals living in the endemic areas of FS.
In summary, our findings further
support the notion that the anti-Dsg1
response in FS patients may be initiated
by sensitization to an environmental
allergen(s). The crossreactive IgE, IgM,
and pathogenic IgG4 anti-Dsg1 res-
ponse may be the serological markers
of these immunological responses.
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TO THE EDITOR
The occurrence of allergies is rapidly
increasing in the Western world, with
allergic rhinoconjunctivitis to airborne
allergens being the most common con-
dition. The diagnosis of allergic rhino-
conjunctivitis is based on a history of
clinical symptoms, typically during the
pollen season, and skin testing with
the respective allergen. A positive skin
prick test (SPT) is taken as an indication
for IgE-mediated mast cell (MC) degra-
nulation. As it has recently been shown
that pollen release not only allergens
but also bioactive mediators that
can activate and modulate immune
cells (Traidl-Hoffmann et al., 2009), we
hypothesized that non-allergic pollen-
derived factors can induce inflamma-
tion both in patients and in non-allergic
mice. We, therefore, assessed the levels
of specific IgE against birch or ambrosia
in 184 consecutive patients seen at the
outpatient clinics of the Allergie-Cen-
trum-Charite´ in Berlin, Germany, with a
positive history for allergic symptoms to
birch (146 patients) or ambrosia (38
patients), and positive SPT to the res-
pective allergens. In accordance with
previously reported findings (Bodtger
et al., 2003), we found that 13% of our
patients with positive SPT to birch hadAbbreviations: APE, aqueous pollen extract; MC, mast cell; SPT, skin prick test
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